FDA To Weigh Public Input On Biosimilars Program
By Derek Hawkins · December 6, 2011, 7:29 PM EST
The U.S. Food and Drug Administration said Monday it would hold a public hearing to seek stakeholder input on the agency's proposed user fee program for biosimilar biological products, a move...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login